Buscar
Phibro Animal Health Corp
PAHCAñadir a la lista de seguimiento
34.370USD
-1.780-4.92%
Cierre 05/15, 16:00（ET）Cotizaciones retrasadas 15 min
1.39BCap. mercado
14.63P/E TTM
Más Datos de Phibro Animal Health Corp Compañía
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Información de Phibro Animal Health Corp
Símbolo de cotizaciónPAHC
Nombre de la empresaPhibro Animal Health Corp
Fecha de salida a bolsaApr 11, 2014
Director ejecutivoBendheim (Jack C)
Número de empleados2475
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 11
DirecciónGlenpointe Centre East, 3Rd Floor
CiudadTEANECK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal07666
Teléfono12013297300
Sitio Webhttps://www.pahc.com/
Símbolo de cotizaciónPAHC
Fecha de salida a bolsaApr 11, 2014
Director ejecutivoBendheim (Jack C)
Ejecutivos de Phibro Animal Health Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
47.47K
+36.80%
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+3.98%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-17.28%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Jack C. Bendheim
Mr. Jack C. Bendheim
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Ms. Mary Lou Malanoski
Ms. Mary Lou Malanoski
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
47.47K
+36.80%
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+3.98%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-17.28%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
MFAs and Other
202.11M
54.05%
Nutritional specialties
50.23M
13.43%
Vaccines
37.64M
10.07%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
221.76M
59.31%
Latin America and Canada
87.60M
23.43%
Europe & Middle East & Africa
44.78M
11.98%
Asia Pacific
19.77M
5.29%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
MFAs and Other
202.11M
54.05%
Nutritional specialties
50.23M
13.43%
Vaccines
37.64M
10.07%
Estadísticas de accionistas
Actualizado: dom., 10 de may
Actualizado: dom., 10 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.89%
State Street Investment Management (US)
4.47%
Vanguard Capital Management, LLC
4.23%
Millennium Management LLC
3.04%
Acadian Asset Management LLC
2.93%
Otro
71.44%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.89%
State Street Investment Management (US)
4.47%
Vanguard Capital Management, LLC
4.23%
Millennium Management LLC
3.04%
Acadian Asset Management LLC
2.93%
Otro
71.44%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
53.06%
Investment Advisor/Hedge Fund
28.56%
Hedge Fund
10.67%
Research Firm
2.76%
Pension Fund
1.42%
Bank and Trust
0.69%
Individual Investor
0.59%
Corporation
0.46%
Family Office
0.39%
Otro
1.42%
Participación institucional
Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
474
22.03M
104.57%
-645.50K
2025Q4
432
20.14M
97.68%
-3.60M
2025Q3
390
21.83M
106.75%
-2.29M
2025Q2
377
20.85M
102.34%
-3.11M
2025Q1
383
21.67M
106.42%
-2.98M
2024Q4
360
21.95M
107.94%
-1.91M
2024Q3
348
21.46M
105.50%
-2.61M
2024Q2
357
21.32M
104.83%
-3.05M
2024Q1
350
21.49M
105.66%
-2.40M
2023Q4
349
21.13M
103.91%
-1.66M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
2.93M
14.19%
+6.03K
+0.21%
Dec 31, 2025
State Street Investment Management (US)
942.28K
4.57%
+48.24K
+5.40%
Dec 31, 2025
Millennium Management LLC
641.31K
3.11%
+626.49K
+4227.06%
Dec 31, 2025
Acadian Asset Management LLC
702.65K
3.41%
-83.17K
-10.58%
Dec 31, 2025
Geode Capital Management, L.L.C.
569.11K
2.76%
+21.95K
+4.01%
Dec 31, 2025
Renaissance Technologies LLC
545.30K
2.64%
-9.90K
-1.78%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
492.33K
2.39%
+6.83K
+1.41%
Dec 31, 2025
Fidelity Management & Research Company LLC
477.06K
2.31%
+63.44K
+15.34%
Dec 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
AAM Sawgrass US Small Cap Quality Growth ETF
2.49%
State Street SPDR S&P Pharmaceuticals ETF
1.19%
Innovator IBD 50 Fund ETF
1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
1.06%
Inspire Fidelis Multi Factor ETF
1.06%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.02%
Lattice Hartford Multifactor Small Cap ETF
0.92%
Invesco Dorsey Wright Healthcare Momentum ETF
0.76%
Invesco NASDAQ Future Gen 200 ETF
0.61%
Invesco S&P SmallCap Health Care ETF
0.52%
Ver más
AAM Sawgrass US Small Cap Quality Growth ETF
Proporción2.49%
State Street SPDR S&P Pharmaceuticals ETF
Proporción1.19%
Innovator IBD 50 Fund ETF
Proporción1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
Proporción1.06%
Inspire Fidelis Multi Factor ETF
Proporción1.06%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporción1.02%
Lattice Hartford Multifactor Small Cap ETF
Proporción0.92%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporción0.76%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.61%
Invesco S&P SmallCap Health Care ETF
Proporción0.52%
Dividendos
Un total de
97.20M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
May 05, 2026
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Jun 24, 2026 going ex on Jun 03, 2026
Jun 03, 2026
Jun 24, 2026
Jun 03, 2026
Feb 03, 2026
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 25, 2026 going ex on Mar 04, 2026
Mar 04, 2026
Mar 25, 2026
Mar 04, 2026
Nov 04, 2025
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 17, 2025 going ex on Nov 26, 2025
Nov 26, 2025
Dec 17, 2025
Nov 26, 2025
Jul 29, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 24, 2025 going ex on Sep 03, 2025
Sep 03, 2025
Sep 24, 2025
Sep 03, 2025
May 06, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 25, 2025 going ex on Jun 04, 2025
Jun 04, 2025
Jun 25, 2025
Jun 04, 2025
Feb 04, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 26, 2025 going ex on Mar 05, 2025
Mar 05, 2025
Mar 26, 2025
Mar 05, 2025
Nov 05, 2024
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 18, 2024 going ex on Nov 27, 2024
Nov 27, 2024
Dec 18, 2024
Nov 27, 2024
Jul 30, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 25, 2024 going ex on Sep 04, 2024
Sep 04, 2024
Sep 25, 2024
Sep 04, 2024
May 07, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 26, 2024 going ex on Jun 05, 2024
Jun 05, 2024
Jun 26, 2024
Jun 05, 2024
Feb 06, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 27, 2024 going ex on Mar 05, 2024
Mar 06, 2024
Mar 27, 2024
Mar 05, 2024
Ver más
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
